Elbasvir
Zepatier (elbasvir) is a small molecule pharmaceutical. Elbasvir was first approved as Zepatier on 2016-01-28. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Zepatier's patent is valid until 2031-05-04 (FDA).
| Trade Name | Zepatier |
|---|---|
| Common Name | Elbasvir |
| Indication | chronic hepatitis c, hepatitis c |
| Drug Class | Antivirals: NS5A inhibitors |
